| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |